| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 929 | 1,057 | 1,028 | 1,064 | 1,052 | 1,068 | 1,055 | 1,002 | 702 | 1,011 | 993 | 1,137 | 1,112 | 1,273 | 1,386 | 1,395 | 1,514 | 1,521 | 1,291 | 1,221 | 1,192 | 1,218 | 1,155 | 1,228 | 1,338 | 1,428 | 1,436 | 1,502 |
| Expenses | 762 | 836 | 818 | 855 | 800 | 821 | 792 | 777 | 502 | 741 | 710 | 862 | 844 | 1,031 | 1,129 | 1,165 | 1,244 | 1,267 | 1,096 | 1,046 | 1,000 | 1,039 | 986 | 1,065 | 1,099 | 1,150 | 1,193 | 1,229 |
| EBITDA | 167 | 221 | 210 | 209 | 251 | 247 | 263 | 225 | 200 | 270 | 283 | 275 | 268 | 241 | 257 | 229 | 270 | 254 | 195 | 175 | 192 | 180 | 169 | 164 | 240 | 277 | 243 | 273 |
| Operating Profit % | 17 % | 19 % | 21 % | 19 % | 23 % | 21 % | 24 % | 19 % | 24 % | 26 % | 26 % | 23 % | 22 % | 17 % | 18 % | 15 % | 16 % | 15 % | 14 % | 13 % | 15 % | 13 % | 13 % | 12 % | 17 % | 17 % | 16 % | 15 % |
| Depreciation | 28 | 29 | 29 | 33 | 32 | 32 | 32 | 34 | 33 | 33 | 33 | 37 | 43 | 44 | 45 | 44 | 47 | 49 | 50 | 51 | 52 | 54 | 61 | 76 | 77 | 78 | 81 | 82 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 5 | 5 | 9 | 4 | 5 |
| Profit Before Tax | 137 | 190 | 179 | 174 | 218 | 212 | 227 | 188 | 164 | 235 | 247 | 236 | 222 | 196 | 210 | 182 | 221 | 203 | 142 | 122 | 139 | 124 | 105 | 83 | 158 | 191 | 158 | 186 |
| Tax | 54 | 67 | 63 | 61 | 69 | 2 | 57 | 46 | 46 | 60 | 57 | 59 | 57 | 50 | 53 | 45 | 58 | 54 | 39 | 30 | 36 | 33 | 33 | 24 | 46 | 51 | 41 | 56 |
| Net Profit | 83 | 124 | 117 | 113 | 149 | 210 | 170 | 143 | 118 | 175 | 190 | 177 | 165 | 146 | 157 | 137 | 164 | 148 | 103 | 92 | 102 | 91 | 72 | 59 | 112 | 140 | 117 | 130 |
| EPS in ₹ | 27.44 | 41.21 | 39.46 | 37.61 | 49.67 | 70.45 | 56.95 | 47.62 | 39.71 | 58.78 | 63.58 | 59.04 | 56.09 | 49.56 | 52.53 | 46.05 | 55.70 | 51.11 | 35.60 | 31.69 | 35.02 | 30.60 | 24.04 | 19.81 | 38.00 | 46.47 | 36.93 | 42.97 |
ATUL
6,832.00
-30.00
(-0.44%)
Market Cap
20,114.61 Cr
EPS
109.54
PE Ratio
41.84
Dividend Yield
0.36 %
Industry
Chemicals52 Week High
8,180.00
52 Week Low
4,752.00
PB Ratio
3.62
Debt to Equity
0.03
Sector
Specialty Chemicals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from10 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
2,957.50 | #1 1,50,432.50 | 75.66 | 12,522.60 | #1 5.69 | #1 1,747 | 40.49 | 49.60 | |
2,952.80 | 87,528.32 | 78.92 | 13,221.50 | -11.53 | 1,336 | 6.99 | 49.54 | |
3,933.60 | 43,210.60 | 93.82 | 4,387.70 | -25.09 | 435 | 57.50 | 54.55 | |
1,904.20 | 25,971.96 | 39.24 | 7,757.90 | -3.26 | 811 | -51.46 | 42.98 | |
4,548.20 | 22,547.03 | 87.82 | 2,120.90 | 0.37 | 271 | 7.18 | 62.93 | |
430.55 | 21,255.45 | 37.84 | 4,227.40 | 0.66 | 411 | 34.98 | 45.56 | |
6,832.00 | #7 20,114.61 | #4 41.84 | #6 4,783.90 | #8 -13.69 | #8 324 | #1 121.26 | 68.06 | |
4,328.10 | 18,734.46 | #1 31.30 | #1 13,843.30 | - | 563 | -26.05 | 41.67 | |
1,617.70 | 16,769.99 | 44.33 | 1,938.80 | -8.77 | 323 | 21.85 | 49.71 | |
448.55 | 16,260.80 | 45.56 | 6,380.70 | -3.61 | 417 | -27.27 | 59.75 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-13.69 %
Net Income Growth
-36.02 %
Cash Flow Change
-5.55 %
ROE
-41.53 %
ROCE
-41.50 %
EBITDA Margin (Avg.)
-9.47 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,823 | 2,479 | 2,727 | 3,014 | 3,544 | 4,151 | 4,937 | 5,706 | 5,768 | 6,476 |
| Fixed Assets | 514 | 753 | 1,026 | 1,027 | 1,104 | 1,110 | 1,402 | 1,617 | 1,750 | 2,771 |
| Current Assets | 1,041 | 1,059 | 1,127 | 1,356 | 1,662 | 2,082 | 2,564 | 2,689 | 2,091 | 2,276 |
| Capital Work in Progress | 112 | 180 | 59 | 96 | 172 | 368 | 250 | 421 | 1,033 | 281 |
| Investments | 3 | 379 | 429 | 470 | 752 | 1,137 | 1,361 | 1,339 | 881 | 1,392 |
| Other Assets | 1,195 | 1,167 | 1,213 | 1,420 | 1,515 | 1,535 | 1,925 | 2,331 | 2,104 | 2,032 |
| Total Liabilities | 1,823 | 2,479 | 2,727 | 3,014 | 3,544 | 4,151 | 4,937 | 5,706 | 5,768 | 6,476 |
| Current Liabilities | 638 | 706 | 588 | 569 | 577 | 732 | 806 | 999 | 840 | 888 |
| Non Current Liabilities | 140 | 156 | 158 | 181 | 237 | 237 | 274 | 248 | 208 | 425 |
| Total Equity | 1,045 | 1,617 | 1,981 | 2,264 | 2,730 | 3,181 | 3,857 | 4,460 | 4,719 | 5,163 |
| Reserve & Surplus | 1,009 | 1,585 | 1,936 | 2,214 | 2,676 | 3,125 | 3,797 | 4,399 | 4,642 | 5,085 |
| Share Capital | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 16 | -13 | 5 | 19 | -5 | -11 | 21 | 11 | -20 | 22 |
| Investing Activities | -167 | -375 | -175 | -129 | -408 | -782 | -645 | -163 | -469 | -683 |
| Operating Activities | 306 | 401 | 392 | 356 | 404 | 881 | 718 | 231 | 707 | 668 |
| Financing Activities | -124 | -39 | -212 | -207 | -1 | -111 | -52 | -57 | -258 | 38 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 44.93 % | 44.93 % | 44.94 % | 44.94 % | 44.94 % | 45.05 % | 45.05 % | 45.06 % | 45.06 % | 45.06 % | 45.06 % | 45.07 % | 45.17 % | 45.17 % | 45.17 % | 45.17 % | 45.18 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 7.71 % | 8.06 % | 8.47 % | 8.63 % | 9.67 % | 11.22 % | 9.79 % |
| DIIs | 23.02 % | 22.23 % | 21.96 % | 21.87 % | 23.10 % | 22.98 % | 22.95 % | 24.22 % | 25.23 % | 25.73 % | 26.51 % | 26.08 % | 25.68 % | 25.82 % | 24.54 % | 22.79 % | 23.62 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % |
| Public / Retail | 18.28 % | 18.21 % | 18.40 % | 18.53 % | 18.20 % | 18.20 % | 17.80 % | 17.30 % | 16.90 % | 16.69 % | 16.28 % | 16.03 % | 16.41 % | 16.35 % | 16.59 % | 16.56 % | 17.13 % |
| Others | 13.77 % | 14.62 % | 14.70 % | 14.66 % | 13.76 % | 13.76 % | 14.19 % | 13.42 % | 12.81 % | 12.52 % | 4.45 % | 4.76 % | 4.27 % | 4.03 % | 4.03 % | 4.26 % | 4.27 % |
| No of Share Holders | 50,197 | 54,214 | 59,726 | 67,025 | 64,429 | 69,679 | 70,248 | 66,455 | 67,542 | 68,751 | 66,776 | 65,757 | 66,589 | 67,753 | 60,354 | 59,110 | 59,642 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 10 | 12 | 15 | 27.5 | 20 | 25 | 32.5 | 20 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.38 | 0.33 | 0.38 | 0.39 | 0.19 | 0.36 | 0.57 | 0.33 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Jul 2025 |  Annual General Meeting | NA | 25 Jul 2025 | 6,232.50 | 6,862.00 |
| 25 Apr 2025 |  Quarterly Result Announcement | NA | 25 Apr 2025 | 5,809.45 | 6,232.50 |
| 24 Jan 2025 | Quarterly Result Announcement | NA | 24 Jan 2025 | 7,032.75 | 6,748.80 |
| 25 Oct 2024 | Quarterly Result Announcement | NA | 25 Oct 2024 | 7,560.50 | 7,645.05 |
| 26 Jul 2024 | Annual General Meeting | NA | 26 Jul 2024 | 5,878.40 | 7,311.50 |
| 13 Jul 2024 |  Dividend | ₹ 20.00 /share | 12 Jul 2024 | 5,878.40 | 6,953.45 |
| 28 Jul 2023 | Annual General Meeting | NA | 28 Jul 2023 | 7,008.20 | 6,510.40 |
| 15 Jul 2023 | Dividend | ₹ 25.00 /share | 14 Jul 2023 | 7,008.20 | 6,561.70 |
| 03 Nov 2022 | Dividend | ₹ 7.50 /share | 02 Nov 2022 | 8,655.95 | 8,359.85 |
| 29 Jul 2022 | Annual General Meeting | NA | 29 Jul 2022 | 9,791.85 | 8,705.40 |
| 16 Jul 2022 | Dividend | ₹ 25.00 /share | 14 Jul 2022 | 9,791.85 | 8,353.40 |
| 17 Jul 2021 | Dividend | ₹ 20.00 /share | 15 Jul 2021 | 8,375.05 | 9,305.00 |
Announcements
Communication To The Members Of The Company Regarding Presentation To The Analysts / Institutional Investors Covering Financial Results For The Year Ended On March 31 2025
3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication10 days ago
10 days agoRecord Date For DividendApr 25, 2025
Apr 25, 2025Appointment Of Secretarial AuditorsApr 25, 2025
Apr 25, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesApr 25, 2025
Apr 25, 2025Financial Results And Outcome Of Board Meeting Attached.Apr 25, 2025
Apr 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 21, 2025
Apr 21, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Update On Insurance Claim Of Fire Incident Of April 20 2022 At Atul SiteApr 01, 2025
Apr 01, 2025Imposition Of Damages By Way Of Penalty And Interest On Provident Fund Contributions.Apr 01, 2025
Apr 01, 2025Announcement under Regulation 30 (LODR)-RetirementMar 29, 2025
Mar 29, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Board Meeting Intimation for Audited Standalone And Consolidated Financial Results And Dividend For The Year Ended On March 31 2025Mar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-RetirementMar 25, 2025
Mar 25, 2025Update On Valsad Institute Of Medical Sciences LtdFeb 13, 2025
Feb 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2025
Feb 06, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 04, 2025
Feb 04, 2025Communication To The Members Of The Company Regarding Financial Results And Investors Presentation For The Third Quarter And Nine Months Ended On December 31 2024Jan 27, 2025
Jan 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 25, 2025
Jan 25, 2025Integrated Filing (Financial)Jan 24, 2025
Jan 24, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJan 24, 2025
Jan 24, 2025Financial ResultsJan 24, 2025
Jan 24, 2025Letter AttachedJan 15, 2025
Jan 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Jan 07, 2025Intimation Regarding Change Of Name Of Link Intime India Private Limited Registrar And Share Transfer Agent Of The CompanyJan 02, 2025
Jan 02, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 16, 2024
Dec 16, 2024Transfer Of Equity Shares To The Investor Education And Protection FundNov 30, 2024
Nov 30, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 29, 2024
Nov 29, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 27, 2024
Nov 27, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 21, 2024
Nov 21, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 05, 2024
Nov 05, 2024Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Oct 29, 2024
Oct 29, 2024Revision In Our Letter Dated October 29, 2024 - Increase In Capacity Of Liquid Epoxy ResinOct 29, 2024
Oct 29, 2024Increase In Capacity Of Liquid Epoxy ResinOct 29, 2024
Oct 29, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 26, 2024
Oct 26, 2024Announcement under Regulation 30 (LODR)-Investor PresentationOct 25, 2024
Oct 25, 2024Financial Results For Second Quarter And Six Months Ended On September 30, 2024Oct 25, 2024
Oct 25, 2024Announcement under Regulation 30 (LODR)-Change in ManagementOct 15, 2024
Oct 15, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 09, 2024
Oct 09, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024
Oct 08, 2024Closure of Trading WindowSep 25, 2024
Sep 25, 2024Board Meeting Intimation for Financial Results For The Second Quarter / Six Months Ending On September 30, 2024Sep 25, 2024
Sep 25, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 20, 2024
Sep 20, 2024Disclosure Under Regulation 30 Of SEBI LODRSep 10, 2024
Sep 10, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 05, 2024
Sep 05, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 29, 2024
Aug 29, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 10, 2024
Aug 10, 2024Update On The Establishment Inspection Report (EIR) From The United States Food And Drug Administration (USFDA) - Press ReleaseAug 09, 2024
Aug 09, 2024Speech Delivered By The Chairman And Managing Director At The 47Th Annual General MeetingAug 08, 2024
Aug 08, 2024Technical Indicators
RSI(14)
Neutral 68.06
ATR(14)
Less Volatile 273.81
STOCH(9,6)
Overbought 83.47
STOCH RSI(14)
Neutral 71.60
MACD(12,26)
Bullish 71.70
ADX(14)
Strong Trend 38.05
UO(9)
Bearish 67.64
ROC(12)
Uptrend But Slowing Down 14.36
WillR(14)
Overbought -18.19
About ATUL
Atul Limited is a diversified Indian company part of the Lalbhai Group. It primarily operates in Life Science Chemicals and Performance and Other Chemicals, serving various industries worldwide. The company manufactures products such as dyes, dye intermediates, agro-chemicals, aromatics, epoxy resins, and pharma intermediates. Atul has established subsidiaries in the USA, UK, China, Brazil, and UAE to enhance its global presence. The company has multiple manufacturing facilities in India and has implemented various environmental initiatives, including achieving zero liquid effluent discharge in some facilities. Atul has engaged in joint ventures, acquisitions, and expansions to grow its business. It has also focused on research and development, introducing new products and improving existing processes. The company operates through three main segments: Life Science Chemicals, Performance and Other Chemicals, and Others, offering a wide range of products including APIs, crop protection chemicals, adhesion promoters, bulk chemicals, epoxy resins, textile dyes, and agribiotech services.
Website
Chairperson NameS S Lalbhai
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
